BioSpace News Archive

Drug Development

Intensity Therapeutics, Inc. Successfully Administers INT230-6 To First Patient In A Phase I/II Trial

May 30, 2017
·
5 min read
Business

Quotient Clinical Appoints Azhar Kalim As Chief Commercial Officer

May 30, 2017
·
3 min read
Genetown

Vedanta Biosciences Granted U.S. Patent Broadly Covering Methods Of Treatment With Therapeutics Based On Bacterial Spore Fractions Of Microbiota Obtained From Human Donors

May 30, 2017
·
4 min read
Policy

Veristat Congratulates Tesaro On The FDA Approval Of ZEJULA

May 30, 2017
·
3 min read
Business

Alkermes Appoints Craig Hopkinson, M.D., As Chief Medical Officer, And Senior Vice President, Clinical Development And Medical Affairs

May 30, 2017
·
4 min read
Business

Concert Pharma Announces Departure Of Chief Financial Officer, Ryan Daws

May 30, 2017
·
1 min read
FDA

Merck & Co. Receives FDA Approval Of ISENTRESS HD (Raltegravir), A New Once-Daily Option, In Combination With Other Antiretroviral Agents, For The Treatment Of HIV-1 Infection In Appropriate Patients

May 30, 2017
·
11 min read
FDA

Novartis AG Receives FDA Approval For Expanded Use Of Zykadia In First-Line ALK-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)

May 30, 2017
·
13 min read
Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

May 30, 2017
·
5 min read
Drug Development

AMO Pharma Announces FDA Fast Track Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy

May 30, 2017
·
3 min read